#85 ep3.3_Non-ibogaine Iboga Alkaloids_Surajit Sinha
Dr. Surajit Sinha speaks about his research into non-ibogaine iboga-type minor alkaloids that get far less attention compared to ibogaine.
Dr. Surajit Sinha speaks about his research into non-ibogaine iboga-type minor alkaloids that get far less attention compared to ibogaine.
Dr. Lowan H. Stewart and I discuss dissociativeness and other overlaps between ketamine and iboga, both NMDA antagonists.
Dr. Peter H. Addy and I compare notes on the neuroscience and phenomenology of Salvia divinorum and iboga, both kappa opioid agonists.
My thoughts about producing Season 3 of Iboganautics podcast. This season’s episodes focus on the Neuro & Plant Science of iboga.
Some thoughts about attending my first iboga conference: Universal Ibogaine Conference 2021.
Applications and implications of psychedelic cryptography, that is, hiding messages in images and videos that only psychedelics can decrypt.
Can iboga reverse damage caused by a vaccine’s toxins? I doubt it, but would you risk your life even if there were some questionable toxins?
Free download – “Iboga Information Document for First Responders.” Fill out drug/patient info, then give to first responders in emergencies.
Paramedic Program Director, Art Hsieh, walks us through first responder processes in assisting patients with non-ordinary consciousness.
Computational psychologist Andrés Gómez Emilsson speaks about psychedelic-induced tracer effects and QRI’s new Tracer Replication Tool.